Device
Vagal stimulation
Vagal stimulation is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed250%
active_not_recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
completednot_applicable
Autoimmune Basis for Postural Tachycardia Syndrome
NCT05043051
active_not_recruitingphase_1
Vagal Stimulation in POTS
NCT03124355
active_not_recruitingnot_applicable
Effect of Stimulation on the Vagus Nerve
NCT04206540
completednot_applicable
Vagal Nerve Stimulation as Therapeutic Approach on Metabolic Syndrome
NCT05785117
Clinical Trials (4)
Showing 4 of 4 trials
NCT05043051Not Applicable
Autoimmune Basis for Postural Tachycardia Syndrome
NCT03124355Phase 1
Vagal Stimulation in POTS
NCT04206540Not Applicable
Effect of Stimulation on the Vagus Nerve
NCT05785117Not Applicable
Vagal Nerve Stimulation as Therapeutic Approach on Metabolic Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4